Journal ArticleOPEN ACCESS

Fluoxetine for multiple sclerosis

Cochrane Database of Systematic Reviews (2018) 2018(9)
DOI: 10.1002/14651858.CD009866.pub2
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis.

Cite

CITATION STYLE

APA

Hosseini, R., Tajdini, M., Modabbernia, A., Akhondzadeh, S., & Tafakhori, A. (2018). Fluoxetine for multiple sclerosis. Cochrane Database of Systematic Reviews, 2018(9). https://doi.org/10.1002/14651858.CD009866.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free